Table 1.
Media names, components and functions within the context of this study.
| Name | Components | Function |
|---|---|---|
| OB medium | DMEM low glucose 10 % FBS 1 % anti-anti 50 μg/mL L-ascorbic-acid-2-phosphate 100 nM dexamethasone 10 mM β-glycerophosphate |
Osteogenic medium. One of three media compared during the co-culture. This medium was expected to further stimulate mineralized matrix deposition by OB. |
| Neutral medium | RPMI-1640 10 % FBS 1 % Anti-Anti |
Unsupplemented medium. One of three media compared during the co-culture. This medium was expected to allow OB and OC crosstalk to control ongoing matrix deposition and resorption. |
| OC medium | RPMI-1640 10 % FBS 1 % Anti-Anti 50 ng/mL M-CSF 50 ng/mL RANKL |
Osteoclastogenic medium. One of three media compared during the co-culture. This medium was expected to stimulate OC resorption. |
| MSC expansion medium | DMEM high glucose 10 % FBS 1 % anti-anti 1 % NEAA 1 ng/L bFGF |
Used to expand MSCs prior to seeding onto scaffolds. |
| MSC seeding medium | DMEM high glucose 10 % FBS 1 % anti-anti |
Unsupplemented medium that is used for MSC seeding onto scaffolds and prewetting of scaffolds. |
| Monocyte priming medium | RPMI-1640 10 % FBS 1 % Anti-Anti 50 ng/mL M-CSF |
Used to prime monocytes during the first two days of culture which benefits osteoclastogenic differentiation. |